Clinical Pathways NEXT: Practice Changing Therapies

Date
Thursday, March 5, 2026
 
Time
12:00 PM (UTC-05:00) Eastern Time (US & Canada)
 
Duration
60 minutes
 
Description

What constitutes a practice changing therapy that would warrant an off-cycle review for pathways? Clinical pathways rely on timely evidence, but not every new approval warrants immediate change. This webinar explores what truly defines a practice-changing oncology therapy, the clinical and operational thresholds for off-cycle pathway reviews, and how practices can balance innovation, consistency, and real-world resource constraints.

 

This is a non-CME event. By registering for this program, you consent to share your registration information with the program's sponsor.

 

 

Speakers

Gordon Kuntz (Moderator)
Gordon Kuntz (Moderator)
President
Kuntz Consulting

Linda Bosserman, MD, PhD, FASO, FACP
Linda Bosserman, MD, PhD, FASO, FACP
Medical Director, Value Based Care & Center for International Medicine
City of Hope

Victoria Handy, PharmD, BCOP, PMP
Victoria Handy, PharmD, BCOP, PMP
Director, Clinical Content
The US Oncology Network

David Jackman, MD
David Jackman, MD
Medical Director of Clinical Pathways
Dana-Farber Cancer Institute